Pleomorphic xanthoastrocytoma (PXA) is a rare primary CNS tumor. Recent advances in the
molecular characterization are helping to define subtypes of tumor. The discovery of BRAF …

Prognostic significance of histological anaplasia and BRAF V600E mutation were
retrospectively evaluated in 74 patients with pleomorphic xanthoastrocytoma (PXA). Median …

Published in 2021, the fifth edition of the World Health Organization (WHO) classification of
tumors of the central nervous system (CNS) introduced new molecular criteria for tumor …

Epithelioid glioblastoma (eGBM) is a rare variant of GBM which was adopted in the 2016
WHO classification. eGBM and pleomorphic xanthoastrocytoma (PXA) sometimes show …

BACKGROUND AND PURPOSE: Anaplastic pleomorphic xanthoastrocytoma, which has
been recently defined as a distinct entity in the 2016 World Health Organization …

BACKGROUND AND PURPOSE: Pleomorphic xanthoastrocytomas are rare astrocytic
neoplasms of childhood and young adulthood. The purpose of this retrospective review was …

Pleomorphic Xanthoastrocytoma [PXA] is a rare low grade glial tumor commonly affecting
young adults. We did this systematic review and meta-analysis to identify prognostic factors …

Abstract Introduction Pleomorphic xanthoastrocytomas (PXAs) are classified as a grade II
neoplasm, typically occur in children, and have favorable prognoses. However, their …

Background Pleomorphic xanthoastrocytoma (PXA) is a rare, low-grade glioma that
frequently occurs in pediatric patients. Objective To analyze adult patients diagnosed with …

Pleomorphic xanthoastrocytomas (PXA) are rare, accounting for< 1% of all astrocytomas.
Literature on the clinical course and treatment outcomes of PXAs is limited. The study aimed …